Replies to post #12243 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>The cash-burn reduction already includes the $5 from Ovation.<

That’s right. The $7M reduction in burn relative to prior guidance also (presumbly) includes $2M of incremental revenue from Leo and/or Merrimack.

I posted the relevant portion of slide #24 in the previous message.